This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vijapurkar, U. Articles by Largman, C. Search for Related Content PubMed PubMed Citation Articles by Vijapurkar, U. Articles by Largman, C.

Protein Kinase C-Mediated Phosphorylation of the Leukemia-Associated HOXA9 Protein Impairs Its DNA Binding Ability and Induces Myeloid Differentiation

Department of Medicine, University of California VA Medical Center, San Francisco, California 94121,¹ Comprehensive Cancer Center, University of California, San Francisco, California 94115²

Received 30 September 2003/ Returned for modification 2 December 2003/ Accepted 5 February 2004

HOXA9 expression is a common feature of acute myeloid leukemia, and high-level expression is correlated with poor prognosis. Moreover, HOXA9 overexpression immortalizes murine marrow progenitors that are arrested at a promyelocytic stage of differentiation when cultured and causes leukemia in recipient mice following transplantation of HOXA9 expressing bone marrow. The molecular mechanisms underlying the physiologic functions and transforming properties of HOXA9 are poorly understood. This study demonstrates that HOXA9 is phosphorylated by protein kinase C (PKC) and casein kinase II and that PKC mediates phosphorylation of purified HOXA9 on S204 as well as on T205, within a highly conserved consensus sequence, in the N-terminal region of the homeodomain. S204 in the endogenous HOXA9 protein was phosphorylated in PLB985 myeloid cells, as well as in HOXA9-immortalized murine marrow cells. This phosphorylation was enhanced by phorbol ester, a known inducer of PKC, and was inhibited by a specific PKC inhibitor. PKC-mediated phosphorylation of S204 decreased HOXA9 DNA binding affinity in vitro and the ability of the endogenous HOXA9 to form cooperative DNA binding complexes with PBX. PKC inhibition significantly reduced the phorbol-ester induced differentiation of the PLB985 hematopoietic cell line as well as HOXA9-immortalized murine bone marrow cells. These data suggest that phorbol ester-induced myeloid differentiation is in part due to PKC-mediated phosphorylation of HOXA9, which decreases the DNA binding of the homeoprotein.

This article has been cited by other articles:

• Shen, W.-F., Hu, Y.-L., Uttarwar, L., Passegue, E., Largman, C. (2008). MicroRNA-126 Regulates HOXA9 by Binding to the Homeobox. Mol. Cell. Biol. 28: 4609-4619 [Abstract] [Full Text]  
• Bandyopadhyay, S., Ashraf, M. Z., Daher, P., Howe, P. H., DiCorleto, P. E. (2007). HOXA9 Participates in the Transcriptional Activation of E-Selectin in Endothelial Cells. Mol. Cell. Biol. 27: 4207-4216 [Abstract] [Full Text]  
• Pearn, L., Fisher, J., Burnett, A. K., Darley, R. L. (2007). The role of PKC and PDK1 in monocyte lineage specification by Ras. Blood 109: 4461-4469 [Abstract] [Full Text]  
• Storlie, J., Jackson, W., Hutchinson, J., Grose, C. (2006). Delayed Biosynthesis of Varicella-Zoster Virus Glycoprotein C: Upregulation by Hexamethylene Bisacetamide and Retinoic Acid Treatment of Infected Cells. J. Virol. 80: 9544-9556 [Abstract] [Full Text]  
• Shen, W., Chrobak, D., Krishnan, K., Lawrence, H. J., Largman, C. (2004). HOXB6 Protein Is Bound to CREB-binding Protein and Represses Globin Expression in a DNA Binding-dependent, PBX Interaction-independent Process. J. Biol. Chem. 279: 39895-39904 [Abstract] [Full Text]